產(chǎn)品名稱 P 005091 - P 5091
產(chǎn)品貨號(hào) Axon 2011 CAS [882257-11-6] MF C12H7Cl2NO3S2MW 348.22 Purity: 99% Soluble in DMSO Description Selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) and the closely related USP47; inhibits USP7-mediated p53 deubiquitination; enhances the degradation of the USP7 substrate HDM2 in tumor cells; induces apoptosis in MM cells resistant to conventional and bortezomib (Axon 1810) therapies References Certificates Categories Extra info B Nicholson, KGS Kumar. The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem. Biophys. 2011, 60(1-2), 61-68.? ? D Chauhan et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell. 2012, 22(3), 345-358. Certificate of Analysis Material Safety Data Sheet Apoptosis Cell Signaling & Oncology Ubiquitin EC 3.4.19.12 Deubiquitinase Inhibitor of deubiquitinase USP7 and USP47 Chemical name 1-(5-(2,3-dichlorophenylthio)-4-nitrothiophen-2-yl)ethanone Parent CAS No. [882257-11-6] Order Size Unit Price Stock 10 mg €95.00 In Stock
產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià)，電話：010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

P 005091 - P 5091

Based on 15 reference(s) in Google Scholar 8 10 15

Axon 2011

CAS [882257-11-6]

MF C12H7Cl2NO3S2
MW 348.22

  • Purity: 99%
  • Soluble in DMSO

P 005091

Description

Selective and potent inhibitor of ubiquitin-specific protease 7 (USP7) and the closely related USP47; inhibits USP7-mediated p53 deubiquitination; enhances the degradation of the USP7 substrate HDM2 in tumor cells; induces apoptosis in MM cells resistant to conventional and bortezomib (Axon 1810) therapies
產(chǎn)品資料